Adenine phosphoribosyltransferase

Adenine Phosphoribosyltransferase (APRT) is an enzyme that plays a crucial role in the purine metabolism pathway, specifically in the salvage pathway of adenine recycling. APRT catalyzes the conversion of adenine and 5-phosphoribosyl-1-pyrophosphate (PRPP) into adenosine monophosphate (AMP) and pyrophosphate. This reaction is vital for the conservation of purine bases and for maintaining the balance of nucleotide pools within the cell.

Function

APRT belongs to the purine salvage pathway, which is essential for the reuse of purines generated from the degradation of nucleic acids. This pathway is crucial for cell economy and viability, especially in cells that divide rapidly and have high nucleotide turnover rates. By converting adenine to AMP, APRT helps to ensure a steady supply of adenine nucleotides, which are required for DNA and RNA synthesis, energy metabolism, and signal transduction.

Structure

The APRT enzyme is a homodimer, meaning it consists of two identical subunits. Each subunit contains a binding site for adenine and PRPP. The structure of APRT is highly conserved across different species, indicating the enzyme's essential role in cellular metabolism.

Genetic and Clinical Significance

Mutations in the APRT gene can lead to APRT deficiency, a rare genetic disorder. This condition is characterized by the accumulation of 2,8-dihydroxyadenine (DHA) crystals in the urinary tract, leading to kidney stones and potentially kidney failure. APRT deficiency can be managed with dietary modifications and medication to reduce the production of DHA.

Diagnosis and Treatment

Diagnosis of APRT deficiency involves biochemical tests to measure enzyme activity and genetic testing to identify mutations in the APRT gene. Treatment typically includes a low-purine diet and the administration of allopurinol or febuxostat, which are medications that reduce the production of uric acid and DHA.

Research Directions

Research on APRT and its associated pathways continues to provide insights into purine metabolism and its disorders. Studies on the enzyme's structure and function may lead to improved treatments for APRT deficiency and other related conditions.

‎